Gallagher G, Christie J F, Boyd E, Stimson W H
J Immunol Methods. 1986 Jun 10;90(1):57-64. doi: 10.1016/0022-1759(86)90383-2.
We have developed and characterised a variant of the human T-cell tumour, MOLT-4F, which is resistant to both 8-azaguanine and 6-thioguanine. This new cell line, M4HS2, is suitable for the efficient production of lymphokine-secreting human T-cell hybrids and is available for distribution.
我们已经开发并鉴定了一种人类T细胞肿瘤变体MOLT-4F，它对8-氮杂鸟嘌呤和6-硫代鸟嘌呤均具有抗性。这种新的细胞系M4HS2适用于高效生产分泌淋巴因子的人类T细胞杂交瘤，并且可供分发。
